Expedited Criteria encompass the set of prerequisites that must be satisfied to facilitate expedited reporting. The fundamental conditions mandated for such rapid reporting encompass four essential elements: the presence of an identifiable patient, accurate identification of the suspect medicinal product’s name, clear identification of the reporting source, and the occurrence of an event or outcome that can be classified as both serious and unexpected.
These stringent criteria collectively serve as a critical framework to ensure timely and efficient communication of pertinent information in instances where expedited reporting is warranted, prioritizing the swift dissemination of vital data.
Confounding by Indication
Contact our experts today
Composed of proven experts from the pharmaceutical industry, our team is ready to answer to your needs in any
area of product development, commercialisation and early access programs, and life cycle management